As of 2025-05-17, the Intrinsic Value of Genprex Inc (GNPX) is -4.37 USD. This GNPX valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.25 USD, the upside of Genprex Inc is -1,868.14%.
Based on its market price of 0.25 USD and our intrinsic valuation, Genprex Inc (GNPX) is overvalued by 1,868.14%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.37 - -4.37 | -4.37 | -1,868.14% |
| P/E | (15.46) - (19.77) | (18.14) | -7437.8% |
| DDM - Stable | (4.66) - (12.41) | (8.54) | -3553.7% |
| DDM - Multi | (3.63) - (8.01) | (5.05) | -2144.7% |
| Market Cap (mil) | 5.97 |
| Beta | -2.81 |
| Outstanding shares (mil) | 24.15 |
| Enterprise Value (mil) | 4.37 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.73% |
| Cost of Debt | 5.00% |
| WACC | 8.70% |